Halozyme Therapeutics
(NASDAQ:HALO)
$40.86
0.13[0.32%]
At close: Mar 28
$40.86
0[0.00%]
After Hours: 7:57PM EDT
62.5%
Overview Rating
Good
Technicals Analysis
100
0100
Financials Analysis
40
0100

Halozyme Therapeutics Stock (NASDAQ:HALO), Quotes and News Summary

Halozyme Therapeutics Stock (NASDAQ: HALO) stock price, news, charts, stock research, profile.

Open$40.820
Close$40.680
Volume / Avg.707.395K / 1.339M
Day Range40.440 - 40.990
52 Wk Range29.850 - 45.000
Market Cap$5.191B
P/E Ratio19.395
Dividend Yield-
ExchangeNASDAQ
RSI
58
Short Interest
8.15%
Days to Cover7.38

Recent News

40%

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change
Analyst Trend
3
Oct 23
1
Dec 23
3
1
Jan
2
Feb
Buy
Hold
Sell
Strong Sell
Analyst Rating
12345
4.1
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell
About Halozyme Therapeutics Inc.
Sector
Health Care
Industry
Biotechnology
Halozyme Therapeutics Inc is a biotechnology company focused on developing and commercializing novel...
Show More

Compare

EPS better than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
HALO
IMVT

FAQ

Q

How do I buy Halozyme Therapeutics (HALO) stock?

A

You can purchase shares of Halozyme Therapeutics (NASDAQ: HALO) through any online brokerage.

View our list of the best stock brokerages.

Q

Who are Halozyme Therapeutics's (HALO) competitors?

Q

What is the target price for Halozyme Therapeutics (HALO) stock?

A

The latest price target for Halozyme Therapeutics (NASDAQ: HALO) was reported by TD Cowen on Thursday, February 29, 2024. The analyst firm set a price target for 54.00 expecting HALO to rise to within 12 months (a possible 32.16% upside). 21 analyst firms have reported ratings in the last year.

Q

Current Stock Price for Halozyme Therapeutics (HALO)?

A

The stock price for Halozyme Therapeutics (NASDAQ: HALO) is $40.86 last updated March 28, 2024 at 7:57 PM EDT.

Q

Does Halozyme Therapeutics (HALO) pay a dividend?

A

There are no upcoming dividends for Halozyme Therapeutics.

Q

When is Halozyme Therapeutics (NASDAQ:HALO) reporting earnings?

A

Halozyme Therapeutics’s Q1 earnings are confirmed for Tuesday, May 7, 2024.

Q

Is Halozyme Therapeutics (HALO) going to split?

A

There is no upcoming split for Halozyme Therapeutics.

Q

What sector and industry does Halozyme Therapeutics (HALO) operate in?

A

Halozyme Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.

People Also Watch